Array
(
    [responseDate] => 2023-12-26T02:38:22Z
    [request] => https://acimed.sld.cu/index.php/acimed/oai
    [GetRecord] => SimpleXMLElement Object
        (
            [record] => SimpleXMLElement Object
                (
                    [header] => SimpleXMLElement Object
                        (
                            [identifier] => oai:acimed.sld.cu:article/1866
                            [datestamp] => 2022-12-14T17:26:36Z
                            [setSpec] => acimed:ART+ORG
                        )

                    [metadata] => SimpleXMLElement Object
                        (
                            [dc] => SimpleXMLElement Object
                                (
                                    [title] => Array
                                        (
                                            [0] => Analysis of Facebook publications and comments about ivermectin during the COVID-19 pandemic in Peru
                                            [1] => Análisis de publicaciones y comentarios sobre la ivermectina en Facebook durante la pandemia del COVID-19 en Perú
                                        )

                                    [creator] => Array
                                        (
                                            [0] => Mujica Rodríguez, Iván Enrique
                                            [1] => Condor Camara, Daniel Flavio
                                            [2] => de la Cruz Rodríguez, Lewis
                                            [3] => Montero Quiñe, Andrea Estefanía
                                            [4] => Bacilio Ruiz, Anthony
                                            [5] => Reyes Solari, Esperanza
                                        )

                                    [subject] => Array
                                        (
                                            [0] => ivermectin; social network; social perception; COVID-19; Peru.
                                            [1] => ivermectina; red social; percepción social; COVID-19; Perú.
                                        )

                                    [description] => Array
                                        (
                                            [0] => The purpose of the study was to analyze Facebook publications and perceptions of users, expressed in their comments, about the drug ivermectin during the COVID-19 pandemic in Peru. The publications and their comments were selected by manual search using the terms “ivermectin” and “#ivermectin” in July 2020. Interpretation of publications and their comments was performed by conventional qualitative content analysis with inductive processing and supported by scientific literature. A total 17 publications were retrieved from the period extending from 18 May to 7 July 2020. These were classified into five topics: rumors (58.8%), based on scientific evidence (11.8%), caution (11.8%), production of the drug (11.8%) and confrontation (5.9%). Paradoxically, 70.0% of the rumors were spread by mass media pages. Comments, on the other hand, were classified into four topics based on user perceptions: ivermectin as “effective cure” (64.8%), request for information about ivermectin (25.3%), against the use of ivermectin (6.3%) and other treatments (3.6%). As a conclusion, it was found that more than half of the information about ivermectin circulating in Facebook publications is classified as “rumors”, and most is spread by mass media pages. Analysis of the comments found that user perception considers ivermectin to be the “effective cure” against COVID-19. 
                                            [1] => Los datos de acceso público en plataformas de redes sociales se pueden utilizar para identificar percepciones, actitudes y sentimientos en relación con la COVID-19; ello puede ser útil para formular políticas de estado y enfrentar adecuadamente la emergencia. El presente trabajo tuvo por objetivo analizar las publicaciones y percepciones de los usuarios a través de sus comentarios en Facebook sobre el fármaco ivermectina durante la pandemia de COVID-19 en Perú. Las publicaciones y sus comentarios fueron seleccionados mediante búsqueda manual, utilizando los términos: “ivermectina” e “#ivermectina”, en julio de 2020. Su interpretación se efectuó por análisis de contenido cualitativo convencional, con proceso inductivo y apoyado por literatura científica. Se encontraron 17 publicaciones realizadas entre el 18 de mayo y 7 de julio del 2020, clasificadas en 5 temáticas: rumores (58,8 %), basadas en evidencia científica (11,8 %), precaución (11,8 %), producción del fármaco (11,8 %) y confrontación (5,9 %). El 70,0 % de los rumores surgieron de páginas de medios de comunicación. Los comentarios se clasificaron, según percepciones de los usuarios hacia la ivermectina, en cuatro temas: ivermectina como “cura efectiva” (64,8 %), solicitud de información (25,3 %), en contra del consumo de ivermectina (6,3 %) y otros tratamientos (3,6 %). Más de la mitad de la información sobre ivermectina en Facebook aparece en “rumores”, en su mayoría originados por páginas de medios de comunicación. Entre los comentarios se destaca la percepción de los usuarios que la consideran “cura efectiva” contra la COVID-19. 
                                        )

                                    [publisher] => ECIMED
                                    [contributor] => Array
                                        (
                                            [0] => SimpleXMLElement Object
                                                (
                                                )

                                            [1] => SimpleXMLElement Object
                                                (
                                                )

                                        )

                                    [date] => 2022-05-27
                                    [type] => Array
                                        (
                                            [0] => info:eu-repo/semantics/article
                                            [1] => info:eu-repo/semantics/publishedVersion
                                            [2] => SimpleXMLElement Object
                                                (
                                                )

                                        )

                                    [format] => application/pdf
                                    [identifier] => https://acimed.sld.cu/index.php/acimed/article/view/1866
                                    [source] => Array
                                        (
                                            [0] => Revista Cubana de Información en Ciencias de la Salud; Vol. 33 (2022): Publicación continua
                                            [1] => 2307-2113
                                        )

                                    [language] => spa
                                    [relation] => Array
                                        (
                                            [0] => https://acimed.sld.cu/index.php/acimed/article/view/1866/pdf
                                            [1] => /*ref*/Chaccour C, Hammann F, Ramón García S, Rabinovich NR. Ivermectin and COVID-19: Keeping rigor in times of urgency. Am J Trop Med Hyg. 2020;102(6):1156-7. DOI: https://doi.org/10.4269/ajtmh.20-0271
                                            [2] => /*ref*/Sharun K, Shyamkumar TS, Aneesha VA, Dhama K, Pawde AM, Pal A. Current therapeutic applications and pharmacokinetic modulations of ivermectin. Vet World. 2019;12(8):1204-11. DOI: https://doi.org/10.14202/vetworld.2019.1204-1211
                                            [3] => /*ref*/Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020;178:104787. DOI: https://doi.org/10.1016/j.antiviral.2020.104787
                                            [4] => /*ref*/BBC News Mundo. La ivermectina y otros medicamentos sin eficacia probada contra el coronavirus que se promueven en América Latina. Londres: BBC; 2020 [acceso 13/02/2021]. Disponible en: https://www.bbc.com/mundo/noticias-america-latina-53389727
                                            [5] => /*ref*/Organización Panamericana de la Salud. Recomendación sobre el uso de ivermectina para el tratamiento de la COVID-19. Washington D.C.: OPS; 2020 jun [acceso 13/02/2021]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52379/OPSIMSCDECOVID-19200033_spa.pdf
                                            [6] => /*ref*/Food and Drug Administration. FAQ: COVID-19 and Ivermectin intended for animals. Maryland: FDA; 2020 [acceso 13/02/2021]. Disponible en: https://www.fda.gov/animal-veterinary/product-safety-information/faq-covid-19-and-ivermectin-intended-animals
                                            [7] => /*ref*/Pan-American Health Organization. Ongoing living update of COVID-19 therapeutic options: summary of evidence. Washington D.C.: PAHO; 2020 dic [acceso 13/02/2021]. Disponible en: https://iris.paho.org/bitstream/handle/10665.2/52719/PAHOIMSEIHCOVID-19200030_eng.pdf
                                            [8] => /*ref*/Salud con lupa. ¿Es peligroso automedicarse con ivermectina? Lima: Salud con lupa; 2020 jul [acceso 13/02/2021]. Disponible en: https://saludconlupa.com/comprueba/es-peligroso-automedicarse-con-ivermectina/
                                            [9] => /*ref*/El Peruano. Resolución Ministerial N.° 947-2020-MINSA, Aprueban documento técnico: Manejo ambulatorio de personas afectadas por la COVID-19 en el Perú. Lima: El Peruano; 2020 nov [acceso 13/02/2021]. Disponible en: https://busquedas.elperuano.pe/normaslegales/aprueban-documento-tecnico-manejo-ambulatorio-de-personas-a-resolucion-ministerial-n-947-2020minsa-1905323-2/
                                            [10] => /*ref*/Soto A. The use of drugs without demonstrated effect as a therapeutic strategy in COVID-19 in Peru. Acta Med Peru. 2020;37(3). DOI: https://doi.org/10.35663/amp.2020.373.1548
                                            [11] => /*ref*/El Comercio. Autoridades reparten ivermectina para vacas para tratar pacientes con coronavirus en Ucayali. Lima: El Comercio; 2020 mayo [acceso 13/02/2021]. Disponible en: https://elcomercio.pe/tecnologia/ciencias/coronavirus-ivermectina-covid-19-en-ucayali-autoridades-reparten-ivermectina-para-animales-para-tratar-pacientes-con-coronavirus-noticia/
                                            [12] => /*ref*/The Scientist Magazine. Surgisphere sows confusion about another unproven COVID-19 drug. New York: The Scientist; 2020 jun [acceso 13/02/2021]. Disponible en: https://www.the-scientist.com/news-opinion/surgisphere-sows-confusion-about-another-unproven-covid19-drug-67635#.XuvRkGUQfjI.email
                                            [13] => /*ref*/Naeem S Bin, Bhatti R, Khan A. An exploration of how fake news is taking over social media and putting public health at risk. Health Info Libr J. 2020;38(2):143-9. DOI: https://doi.org/10.1111/hir.12320
                                            [14] => /*ref*/Wang Z, Ye X. Social media analytics for natural disaster management. Int J Geogr Inf Sci. 2018;32(1):49-72. DOI: https://doi.org/10.1080/13658816.2017.1367003
                                            [15] => /*ref*/Pan-American Health Organization. Entender la infodemia y la desinformación en la lucha contra la COVID-19. Washington D.C.: PAHO; 2020 [acceso 10/03/2021]. Disponible en: https://iris.paho.org/handle/10665.2/52053
                                            [16] => /*ref*/Shorey S, Ang E, Yamina A, Tam C. Perceptions of public on the COVID-19 outbreak in Singapore: a qualitative content analysis. J Public Health (Bangkok). 2020;42(4):665-71. DOI: https://doi.org/10.1093/pubmed/fdaa105
                                            [17] => /*ref*/Islam MS, Sarkar T, Khan SH, Kamal A-HM, Hasan SMM, Kabir A, et al. COVID-19–related infodemic and its impact on public health: a global social media analysis. Am J Trop Med Hyg. 2020;103(4):1621. DOI: https://doi.org/10.4269/ajtmh.20-0812
                                            [18] => /*ref*/El-Awaisi A, O’Carroll V, Koraysh S, Koummich S, Huber M. Perceptions of who is in the healthcare team? A content analysis of social media posts during COVID-19 pandemic. J Interprof Care. 2020;34(5):622-32. DOI: https://doi.org/10.1080/13561820.2020.1819779
                                            [19] => /*ref*/Tsao SF, Chen H, Tisseverasinghe T, Yang Y, Li L, Butt ZA. What social media told us in the time of COVID-19: a scoping review. Lancet Digit Heal. 2021;3(3):e175. DOI: https://doi.org/10.1016/S2589-7500(20)30315-0
                                            [20] => /*ref*/We Are Social. DIGITAL 2021. Londres: We Are Social; 2021 [acceso 15/02/2021]. Disponible en: https://wearesocial.com/digital-2021
                                            [21] => /*ref*/Hu D, Lou X, Xu Z, Meng N, Xie Q, Zhang M, et al. More effective strategies are required to strengthen public awareness of COVID-19: Evidence from google trends. J Glob Health. 2020;10(1):011003. DOI: https://doi.org/10.7189/jogh.10.011003
                                            [22] => /*ref*/Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277-88. DOI: https://doi.org/10.1177/1049732305276687
                                            [23] => /*ref*/Eysenbach G, Till JE. Ethical issues in qualitative research on internet communities. Br Med J. 2001;323(7321):1103-5. DOI: https://doi.org/10.1136/bmj.323.7321.1103
                                            [24] => /*ref*/Mheidly N, Fares J. Leveraging media and health communication strategies to overcome the COVID-19 infodemic. J Public Health Policy. 2020;1-11. DOI: https://doi.org/10.1057/s41271-020-00247-w
                                            [25] => /*ref*/Alvarez Risco A, Mejia CR, Delgado Zegarra J, del Aguila Arcentales S, Arce Esquivel AA, Valladares Garrido MJ, et al. The Peru Approach against the COVID-19 Infodemic: Insights and Strategies. Am J Trop Med Hyg. 2020;103(2):583-6. DOI: https://doi.org/10.4269/ajtmh.20-0536
                                            [26] => /*ref*/Pulido CM, Ruiz Eugenio L, Redondo Sama G, Villarejo Carballido B. A new application of social impact in social media for overcoming fake news in health. Int J Environ Res Public Health. 2020;17(7):2430. DOI: https://doi.org/10.3390/ijerph17072430
                                            [27] => /*ref*/Moneta ME. Apego y pérdida: Redescubriendo a John Bowlby. Rev Chil Pediatr. 2014;85(3):265-8. DOI: http://dx.doi.org/10.4067/S0370-41062014000300001
                                            [28] => /*ref*/Ein Dor T, Hirschberger G. Rethinking attachment theory: from a theory of relationships to a theory of individual and group survival. Curr Dir Psychol Sci. 2016;25(4):223-7. DOI: https://doi.org/10.1177/0963721416650684
                                            [29] => /*ref*/Sánchez Moreno F. El sistema nacional de salud en el Perú. Rev Peru Med Exp Salud Publica. 2014;31(4):747-53. Disponible en: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/129/129
                                            [30] => /*ref*/Plataforma digital única del Estado Peruano. Intervienen local clandestino en el que se almacenaba ivermectina falsificada. Lima: Gobierno del Perú; [acceso 13/02/2021]. Disponible en: https://www.gob.pe/institucion/minsa/noticias/294605-intervienen-local-clandestino-en-el-que-se-almacenaba-ivermectina-falsificada
                                            [31] => /*ref*/Zavala Flores E, Salcedo Matienzo J. Pre-hospitalary medication in COVID-19 patients from a public hospital in Lima-Peru. Acta Med Peru. 2020;37(3). DOI: https://doi.org/10.35663/amp.2020.373.1277
                                            [32] => /*ref*/Centers for Disease Control and Prevention. Cómo protegerse y proteger a los demás. Atlanta: CDC; 2020 [acceso 10/03/2021]. Disponible en: https://espanol.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
                                            [33] => /*ref*/Ipsos. COVID-19 y vacunas. Lima: Ipsos; 2021 feb [acceso 16/02/2021]. Disponible en: https://www.ipsos.com/es-pe/covid-19-y-vacunas-febrero-2021
                                            [34] => /*ref*/Lasco G. Medical populism and the COVID-19 pandemic. Glob Public Health. 2020;15(10):1417-29. DOI: https://doi.org/10.1080/17441692.2020.1807581
                                        )

                                    [rights] => Array
                                        (
                                            [0] => Copyright (c) 2022 Iván Enrique Mujica Rodríguez; Daniel Flavio Condor Camara; Lewis de la Cruz; Andrea Estefanía Montero; Anthony Bacilio Ruiz; Esperanza Reyes Solari.
                                            [1] => http://creativecommons.org/licenses/by-nc-sa/4.0
                                        )

                                )

                        )

                )

        )

)